Andrew Moin
CIK: 0001996040
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SAB Biotherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 29, 2025SABS
SAB Biotherapeutics, Inc.
Exercise(M)Indirect1.7M shares at avg. $1.75$3.0M - Jul 22, 2025SABS
SAB Biotherapeutics, Inc.
Award(A)IndirectSeries B Convertible Preferred Stock
228.5K shares- - Jul 22, 2025SABS
SAB Biotherapeutics, Inc.
Award(A)IndirectWarrants (right to buy)
228.5K shares- - Jul 22, 2025SABS
SAB Biotherapeutics, Inc.
Award(A)IndirectWarrants (right to buy)
114.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 29, 2025 | SABS SAB Biotherapeutics, Inc. | Exercise(M) | 1,740,000 | $1.75 | $3,045,000 | Indirect |
| Jul 22, 2025 | SABS SAB Biotherapeutics, Inc. | Award(A) Series B Convertible Preferred Stock | 228,500 | - | - | Indirect |
| Jul 22, 2025 | SABS SAB Biotherapeutics, Inc. | Award(A) Warrants (right to buy) | 228,500 | - | - | Indirect |
| Jul 22, 2025 | SABS SAB Biotherapeutics, Inc. | Award(A) Warrants (right to buy) | 114,250 | - | - | Indirect |
1-4 of 4 transactions
About Moin Andrew
Moin Andrew (SEC CIK 0001996040) files insider reports with the SEC as Director of SAB Biotherapeutics, Inc. (SABS).
Signal8 holds 2 ownership filings by Moin Andrew, all Form 4s, filed between Jul 24, 2025 and Oct 1, 2025. Those filings report 4 transactions, from Jul 22, 2025 to Sep 29, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Moin Andrew's filings is in MIAMI BEACH, FL.
Recent filings by Moin Andrew
Other insiders filing for SAB Biotherapeutics, Inc. (SABS)
- Kropotova Alexandra, CHIEF MEDICAL OFFICER
- Sullivan Eddie Joe, PRESIDENT
- Reich Samuel J, CEO
- Bausch Christoph Lawrence, CHIEF OPERATING OFFICER
- To Lucy
- Jain Rita, Director